ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 17 of 17 for:    Sandhoff Disease

Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00418847
Recruitment Status : Completed
First Posted : January 5, 2007
Last Update Posted : May 19, 2016
Sponsor:
Collaborator:
Actelion
Information provided by (Responsible Party):
The Hospital for Sick Children

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2009
  Actual Study Completion Date : April 2009